Thursday, September 11, 2025
HomeIndustriesBiotechnology

Biotechnology

Inactivation of Suv39h1 Enhances Anti-Tumor Immune Response by Increasing T Cell Activity

Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, today announced a publication in Nature Communications demonstrating that the histone lysine methyltransferase enzyme Suv39h1 plays...

ClearMind Biomedical Clears FIM Clinical Trial for Least Invasive ICH Treatment to Date

ClearMind Biomedical's novel neurosurgical endoscope, the Axonpen System, has completed its First in Man (FIM) clinical trial in Taiwan with outstanding results. The Axonpen System...

Billion-Euro Market Biotechnology: Exyte Builds mRNA Competence Center for WACKER in Halle

Exyte GmbH (Exyte), a global leader in the design, engineering and delivery of facilities for high-tech industries, is building a mRNA competence center at...

Poxel Announces the Publication of Two Preclinical Articles on X-Linked Adrenoleukodystrophy for PXL065 and PXL770

POXEL SA , a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare...

Innovent Announces Phase 1b Study Results of Mazdutide (IBI362) in Chinese Patients

Innovent Biologics, Inc. ("Innovent"), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
0FansLike
0FollowersFollow
spot_img

Hot Topics